ASTM F2888

ASTM F2888 is the standard practice for platelet leukocyte count, an in-vitro measure used to support hemocompatibility assessment of cardiovascular materials. It provides a structured way to evaluate how a material interacts with blood components under laboratory conditions, helping teams compare products and support technical decision-making. By focusing on platelet and leukocyte counts, the standard offers a practical tool for screening and quality evaluation in cardiovascular material development and testing.

ASTM F2888 standard overview

The ASTM F2888 standard addresses a specific in-vitro practice for measuring platelet and leukocyte count as part of hemocompatibility assessment. Its technical context is centered on cardiovascular materials, where blood-contact performance is often an important part of product evaluation. This standard can help create a more consistent laboratory approach for generating comparative data, supporting procurement, development, and compliance-related testing activities. ASTM F2888 is most useful when a controlled, repeatable method is needed to assess blood-material interaction.

Where is ASTM F2888 used?

This standard is commonly used in laboratory and product evaluation settings focused on cardiovascular materials that contact blood. It may be applied during development, qualification, or comparative testing of materials intended for blood-facing applications. The practice is relevant wherever platelet and leukocyte count measurements are used to support hemocompatibility assessment. ASTM F2888 is therefore a practical reference for technical teams, test labs, and quality groups working with cardiovascular devices or related material systems.

Practical importance of ASTM F2888

ASTM F2888 matters because it helps bring consistency to a specialized blood-contact test method. Using a recognized standard can support more reliable comparisons between materials, improve testing alignment across teams, and reduce uncertainty in evaluation workflows. It is also useful for quality control and documentation when hemocompatibility performance needs to be assessed in a structured way. For organizations sourcing or testing cardiovascular materials, ASTM F2888 can support clearer technical review and more defensible product decisions.

• In-vitro platelet and leukocyte count
• Hemocompatibility assessment support
• Cardiovascular material evaluation
• Comparative laboratory testing
• Quality and procurement reference